COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1763: Articles 17621-17630  | Next

Accounting for imported cases in estimating the time-varying reproductive number of COVID-19
Tim K. Tsang, Peng Wu, Eric H. Y. Lau, Benjamin J. Cowling
10.1101/2021.02.09.21251416 — Posted: 2021-02-12
Temporal trends of SARS-CoV-2 seroprevalence in transfusion blood donors during the first wave of the COVID-19 epidemic in Kenya
Ifedayo M.O. Adetifa, Sophie Uyoga, John N. Gitonga, Daisy Mugo, Mark Otiende, James Nyagwange, Henry K. Karanja, James Tuju, Perpetual Wanjiku, Rashid Aman, Mercy Mwangangi, Patrick Amoth, Kadondi Kasera, Wangari Ng’ang’a, Charles Rombo, Christine Yegon, Khamisi Kithi, Elizabeth Odhiambo, Thomas Rotich, Irene Orgut, Sammy Kihara, Christian Bottomley, Eunice W. Kagucia, Katherine E. Gallagher, Anthony Etyang, Shirine Voller, Teresa Lambe, Daniel Wright, Edwine Barasa, Benjamin Tsofa, Philip Bejon, Lynette I. Ochola-Oyier, Ambrose Agweyu, J. Anthony G. Scott, George M. Warimwe
10.1101/2021.02.09.21251404 — Posted: 2021-02-12
Epidemic transmission with quarantine measures: application to COVID-19
S.A. Trigger, E.B. Czerniawski, A.M. Ignatov
10.1101/2021.02.09.21251288 — Posted: 2021-02-12
Rapid Rise of S-Gene Target Failure and the UK variant B.1.1.7 among COVID-19 isolates in the Greater Toronto Area, Canada
Kevin A. Brown, Jonathan Gubbay, Jessica Hopkins, Samir Patel, Sarah A. Buchan, Nick Daneman, Lee Goneau
10.1101/2021.02.09.21251225 — Posted: 2021-02-12
Emerging SARS-CoV-2 Lineages in Middle Eastern Jordan with Increasing Mutations Near Antibody Recognition Sites
Rima Hajjo, Dima A. Sabbah, Sanaa K. Bardaweel
10.1101/2021.02.09.21251052 — Posted: 2021-02-12
Survey of symptoms following COVID-19 vaccination in India
Rajeev Jayadevan, Ramesh Shenoy, Anithadevi TS
10.1101/2021.02.08.21251366 — Posted: 2021-02-12
Results of an early second PCR test performed on SARS-CoV-2 positive patients may indicate risk for severe COVID-19
Barak Mizrahi, Maytal Bivas-Benita, Nir Kalkstein, Pinchas Akiva, Chen Yanover, Yoav Yehezkelli, Yoav Kessler, Sharon Hermoni Alon, Eitan Rubin, Gabriel Chodick
10.1101/2021.02.09.21251371 — Posted: 2021-02-12
SARS-CoV-2 re-infection risk in Austria
Pilz, S., Chakeri, A., Ioannidis, J. P. A., Richter, L., Theiler-Schwetz, V., Trummer, C., Krause, R., Allerberger, F.
10.1101/2021.02.08.21251362 — Posted: 2021-02-12 Discussion: Onsite
Anti-SARS-CoV-2 seropositivity among medical students in Copenhagen
Madsen, J. R., Nielsen, J. P. S., Fogh, K., Hansen, C. B., Nielsen, P. B., Lange, T., Hasselbalch, R. B., Garred, P., Iversen, K.
10.1101/2021.02.09.21251421 — Posted: 2021-02-12
Associations between measures of social distancing and SARS-CoV-2 seropositivity: a nationwide population-based study in the Netherlands
Vos, E. R. A., van Bove, M., den Hartog, G., Backer, J. A. , Klinkenberg, D., van Hagen, C. C. E., Boshuizen, H., van Binnendijk, R. S. , Mollema, L., van der Klis, F. R. M., de Melker, H. E.
10.1101/2021.02.10.21251477 — Posted: 2021-02-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).